Skip to main content
SINGULAR HEALTH GROUP LTD logo

SINGULAR HEALTH GROUP LTD — Investor Relations & Filings

Ticker · SHG ISIN · AU0000129892 ASX Telecommunications, computer programming, consultancy, computing infrastructure, and other information service activities
Open in API
Filings indexed 364 across all filing types
Latest filing 2021-02-25 Regulatory Filings
Country AU Australia
Listing ASX SHG

About SINGULAR HEALTH GROUP LTD

https://singular.health/

Singular Health Group Ltd specializes in the development and commercialization of medical imaging software designed to enhance personalized healthcare. The company’s primary offering, the 3Dicom software suite, employs proprietary volume rendering technology to transform standard 2D DICOM files, such as CT and MRI scans, into immersive 3D visualizations. This platform supports surgical planning, remote clinical collaboration, and patient education by providing interactive anatomical models. Singular Health integrates artificial intelligence to automate image segmentation and diagnostic workflows, facilitating more precise clinical outcomes. Through its 'Scan to Surgery' initiative, the company bridges the gap between diagnostic imaging and physical intervention using virtual reality and 3D printing. Its solutions target medical practitioners, dental professionals, and healthcare institutions globally.

Recent filings

Filing Released Lang Actions
Half Yearly Report and Accounts 22 pages 645.5KB
Regulatory Filings
2021-02-25 English
Purchase order of $170,000 received for Software Development 3 pages 313.3KB
Capital/Financing Update Classification · 95% confidence The document is an ASX release announcing that Singular Health has received a purchase order of $170,000 for development of GeoVR software. It details the pilot project, joint venture plans, and includes quotes from company executives. There is no financial report, earnings data, or regulatory filing referenced. The content is a corporate announcement about a capital-related transaction (receipt of purchase order and payment schedule for a development project). It does not contain financial statements or detailed financial analysis, nor is it a report or transcript. Therefore, the document fits best under Capital/Financing Update (CAP) as it relates to company fundraising and financing activities.
2021-02-21 English
Investor Presentation 26 pages 1.1MB
Investor Presentation Classification · 95% confidence The document is titled 'Singular Health Group Ltd Investor Presentation' and dated February 2021. It contains detailed information about the company's business, technology, products, market position, management team, and financial snapshot. The text includes forward-looking statements, disclaimers, and corporate overview typical of investor presentations. There is no indication that this is a regulatory filing, earnings release, or annual report. The length is substantial (15,000 characters), and the content is consistent with a presentation aimed at investors to inform them about the company's strategy, technology, and market opportunity. Therefore, the document fits the definition of an Investor Presentation (IP).
2021-02-15 English
Appendix 3X - Initial Director's Interest Notice x 5 10 pages 515.6KB
Director's Dealing Classification · 100% confidence The document is titled 'Appendix 3X Initial Director’s Interest Notice' and references ASX listing rule 3.19A.1 and section 205G of the Corporations Act. It details the securities interests of newly appointed directors, including shares, options, and performance rights, as well as interests in contracts. The content is focused on disclosures of personal shareholdings and interests of directors upon their appointment. This matches the definition of Director's Dealing filings, which report personal share transactions or interests by company directors and executives. The document is not an annual report, earnings release, or any other financial report, nor is it a general regulatory filing or announcement. Therefore, the correct classification is Director's Dealing (DIRS). The document length and detail support a high confidence score.
2021-02-14 English
Becoming a substantial holder 3 pages 253.7KB
Major Shareholding Notification Classification · 100% confidence The document is titled 'Form 603' and references the Corporations Act 2001, specifically Section 671B, which pertains to the notice of an initial substantial holder. The content details the substantial shareholding of an individual named Sim Tek Tan in Singular Health Group Limited, including voting power, relevant interests, registered holders, consideration paid, and associates. This type of filing is a notification of a major shareholding or change in significant ownership levels, which aligns with the definition of 'Major Shareholding Notification' (Code: MRQ). The document is not a financial report, management information, or any other category but specifically a substantial holder notice under Australian corporate law. Therefore, the correct classification is MRQ with high confidence.
2021-02-14 English
Becoming a substantial holder 2 pages 81.8KB
Regulatory Filings
2021-02-14 English

Browse filings by year

6 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.